Administration of IFN-γ reduces the risk of bacterial infection in patients with CGD [17] and can prolong life in some patients in association with restoration of modest activity of the phagocytosis-associated respiratory burst [12]. The gene discussed is IFNG; the disease is chronic granulomatous disease.